CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
An experimental HIV drug from Merck & Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.
The panel of outside experts agreed unanimously that available data support accelerated approval of Isentress, also known as raltegravir, by the Food and Drug Administration.
The FDA isn't required to follow the advice of its outside advisory panels but does so most of the time. Merck expects an agency decision by mid-October. If approved, Isentress would be the first in a new class of antiretroviral drugs called integrase inhibitors.
The Merck drug targets integrase, one of three enzymes used by the virus to replicate and infect cells. The FDA previously has approved drugs that target the two other enzymes, protease and reverse transcriptase.
Isentress is meant to be used as part of a ''cocktail'' of drugs to fight HIV in patients who have developed a resistance to older medications.
Last month, the FDA approved another novel HIV drug, Pfizer Inc.'s Selzentry. That drug is the first that works by blocking a crucial doorway, called the CCR5 receptor, that HIV often uses to enter white blood cells. (AP)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Lauren Boebert Caught Fondling Date’s Genitals During Family-Friendly Musical: Video
September 15 2023 11:20 PM
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Unmasking George Santos: Inside ‘The Fabulist’ With Author Mark Chiusano
December 04 2023 7:12 PM
Tennessee's Controversial Sex Worker Law Discriminates Against Those With HIV: DOJ
December 04 2023 3:54 PM
​Watch 'Saturday Night Live' Give George Santos a Hilarious Congressional Farewell
December 04 2023 1:54 PM
Is Captagon the Next Big Gay Party Drug? The Terrorists Are Counting on It
December 04 2023 12:37 PM
Why Montana’s Two-Spirit People Are Challenging A State Law Defining Sex as Binary
December 04 2023 10:59 AM
Florida School Leaders Punished for Accommodating Transgender Student-Athlete
December 03 2023 1:15 PM